Congenital hypofibrinogenemia: Difference between revisions
CSV import |
CSV import |
||
| Line 36: | Line 36: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Revision as of 11:37, 10 February 2025
Congenital hypofibrinogenemia is a rare, inherited blood disorder characterized by the low levels of fibrinogen in the blood. Fibrinogen is a protein that plays a crucial role in blood clotting.
Symptoms
The symptoms of congenital hypofibrinogenemia can vary greatly from person to person. Some individuals may have no symptoms (asymptomatic) while others may experience excessive bleeding or thrombosis.
Causes
Congenital hypofibrinogenemia is caused by mutations in the FGA, FGB, or FGG genes. These genes provide instructions for making the three parts (alpha, beta, and gamma chains) of the fibrinogen protein.
Diagnosis
Diagnosis of congenital hypofibrinogenemia is based on a clinical evaluation, detailed patient history, and specialized laboratory tests that can measure the amount of fibrinogen in the blood.
Treatment
Treatment is directed toward the specific symptoms that are apparent in each individual. In some cases, treatment may not be necessary. In other cases, treatment may include fibrinogen concentrate or cryoprecipitate to replace the missing fibrinogen.
See also
References
<references />


